From Moonshot to Meltdown: How Market Realities Toppled Ÿnsect, the French Insect-Farming Startup That Raised Over $600 Million

French startup Ÿnsect, once hailed as a trailblazer in sustainable protein production, has now entered judicial liquidation, marking a dramatic fall for a company that once raised over $600 million and attracted high-profile endorsements, including one from Robert Downey Jr. on the “Late Show” during Super Bowl weekend in 2021. This bankruptcy, effectively a form of insolvency, has drawn attention not only because of the company’s ambitious goals but also because it illustrates the complex dynamics of funding, market realities, and industrial scaling in Europe.

Ÿnsect’s ambitions were bold from the start. The company aimed to revolutionize the global food chain by producing insect-based protein, a concept that was innovative and compelling to impact-focused investors. However, despite the significant capital infusion from various sources, including Downey Jr.’s FootPrint Coalition, public funds, and private investors, Ÿnsect struggled to translate vision into sustainable revenue.

Contrary to popular assumptions, the company’s failure was not primarily due to Western consumers’ aversion to eating insects. Human food was never the core market for Ÿnsect. Instead, the company focused on producing insect protein for animal feed and pet food. These two markets have very different economic dynamics and profit margins, and Ÿnsect struggled to identify which to prioritize.

This market indecision was further complicated by its M&A strategy. In 2021, Ÿnsect acquired Protifarm, a Dutch company specializing in mealworm production for human consumption. At the time of the acquisition, then-CEO Antoine Hubert acknowledged that human food would only contribute 10% to 15% of the company’s revenue in the coming years. He also noted that pet food and fish feed would remain the primary revenue drivers, highlighting a disconnect between the acquisition strategy and the urgent need for immediate revenue growth.

Revenue generation was indeed a significant problem. Publicly available data suggests that Ÿnsect’s revenue peaked at €17.8 million ($21 million) in 2021, a figure that may have been inflated by internal transfers between subsidiaries. By 2023, the company reported a net loss of €79.7 million ($94 million), reflecting the gap between its industrial ambitions and market realities.

One of the most perplexing aspects of Ÿnsect’s journey is how a company with such modest revenue could secure over $600 million in investment. The answer lies in the type of investors Ÿnsect attracted. The startup appealed primarily to impact-focused investors, such as Astanor Ventures, and public investment banks like Bpifrance. These investors were drawn to Ÿnsect’s sustainability vision, which offered an alternative to resource-intensive proteins such as fishmeal and soy. This vision resonated with the broader trend toward sustainable agriculture and circular economy solutions, attracting substantial capital even before the business model had proven itself.

However, the lofty vision collided with market realities. Animal feed is a highly price-sensitive commodity market where sustainability often does not translate into a premium. Insect protein production, ideally, would be fully circular, using food waste that would otherwise go to landfill. In practice, industrial-scale insect farming relies on cereal by-products already suitable for animal feed, making the additional step of insect production an expensive proposition. This meant that, for animal feed, the economic model was unviable.

Recognizing this, Ÿnsect began to pivot toward pet food, a market with better margins and less price sensitivity. By 2023, the company sought to focus on higher-margin segments, acknowledging the broader economic pressures, including inflation in energy and raw materials, as well as rising costs of capital. Hubert noted, “We cannot afford to invest loads of resources in markets which are the least remunerative, while there are other markets where there is a lot of demand, good returns, and higher margins.”

Yet, this strategic pivot came too late. By the time Ÿnsect refocused on pet food, it had already invested heavily in the construction of Ÿnfarm, a massive, capital-intensive facility in Northern France touted as “the world’s most expensive bug farm.” The giga-factory was designed for insect production at scale, but it was predicated on market assumptions that no longer aligned with reality. Hundreds of millions in funding were committed to the facility before Ÿnsect had validated its business model or understood its unit economics.

The launch of Ÿnfarm was overseen by Shankar Krishnamoorthy, a former executive at French energy giant Engie, brought in to steer the project. When the pivot to pet food did not save the company, Krishnamoorthy replaced Hubert as CEO. In the ensuing months, Ÿnsect shut down the Protifarm facility and laid off staff, but closing one facility while maintaining a massive, misaligned giga-factory could not solve the fundamental economic issues.

Academics and industry observers have highlighted that Ÿnsect’s failure is not a mystery and is not inherently about insects. Professor Joe Haslam of IE Business School notes, “They are the result of a mismatch between industrial ambition, capital markets, and timing, compounded by some execution and strategy choices.” This analysis suggests that Ÿnsect’s demise is illustrative of broader systemic challenges in scaling industrial startups, particularly in Europe.

The European context, according to Haslam, exacerbates these challenges. “Ÿnsect is a case study in Europe’s scaling gap. We fund moonshots. We underfund factories. We celebrate pilots. We abandon industrialization. See Northvolt, Volocopter, and Lilium,” he said. The implication is that while Europe has the financial and intellectual resources to fund innovative projects, the gap in scaling industrial operations can hinder the long-term viability of deep-tech startups.

The failure of Ÿnsect does not imply a death sentence for the insect farming sector. Competitors such as Innovafeed have fared better, in part because they started with smaller, more manageable production sites and scaled incrementally. This approach contrasts with Ÿnsect’s ambitious giga-factory strategy, which required massive upfront capital without validated revenue streams.

Ÿnsect’s journey also sparked introspection within its leadership. Antoine Hubert, reflecting on the company’s challenges, co-founded Start Industrie, an association advocating for policies to support French industrial startups. This initiative recognizes that Europe’s innovation ecosystem requires more than just funding; it needs policy frameworks and industrial support to bridge the gap between pilot projects and fully scaled production.

In retrospect, several key factors contributed to Ÿnsect’s downfall. First, the company struggled to define its market focus, oscillating between animal feed, pet food, and human food without establishing a clear revenue-generating strategy. Second, the company pursued a high-cost, capital-intensive scaling approach before validating its unit economics. Third, external market forces, including commodity price sensitivity and economic inflation, compounded the operational challenges. Finally, structural issues within the European industrial ecosystem, particularly the difficulty of scaling deep-tech ventures, exacerbated the startup’s vulnerability.

Ÿnsect’s story also sheds light on the investment dynamics in sustainability-focused startups. Impact investors and public funding agencies were willing to support a visionary, environmentally-conscious project, even in the absence of robust near-term financial metrics. While this approach can accelerate innovation, it also introduces risk, particularly when operational execution and market realities are misaligned with visionary goals.

The narrative of Ÿnsect underscores the broader lessons for entrepreneurs, investors, and policymakers. Ambitious visions must be paired with disciplined market analysis and incremental scaling strategies. Industrial-scale operations, particularly in deep-tech sectors, require careful consideration of unit economics, market demand, and competitive dynamics before committing massive capital. Policymakers must recognize that funding innovation alone is insufficient; a supportive ecosystem for industrialization is critical.

In conclusion, Ÿnsect’s judicial liquidation represents the convergence of ambition, timing, market realities, and strategic choices. The company’s vision of sustainable insect protein captured the imagination of investors and the public alike, yet execution missteps, market mismatches, and timing misalignments led to its downfall. While the insect protein sector continues to show promise, Ÿnsect serves as a cautionary tale for the European deep-tech ecosystem, illustrating the challenges of translating moonshot visions into industrial success. Hubert’s post-mortem reflections through Start Industrie suggest a path forward, advocating for structural reforms that enable industrial-scale innovation to thrive, potentially paving the way for the next generation of European deep-tech leaders.